HealthCap VII, L.P. → Aprea Therapeutics, Inc. APRE

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -86.6%

Passive Schedule 13G filer baseline
Short interest building (+22.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 2.23

621,151 shares short · +22.1% vs prior

Other 13D/G Filings on Aprea Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2021-02-16	SC	5AM Ventures IV, L.P.	—	—	view →
2020-11-19	SC	5AM Ventures IV, L.P.	—	—	view →
2020-10-07	SC	5AM Ventures IV, L.P.	—	—	view →
2020-06-16	SC	5AM Ventures IV, L.P.	—	—	view →

Other Filings by HealthCap VII, L.P.

Filed	Form	Issuer	Stake	Shares
2025-09-02	SCHEDULE	Carisma Therapeutics Inc. CARM	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →